Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SYBX | Sell | SYNLOGIC INC | $38,572 | -56.4% | 13,727 | -93.3% | 5.24% | -56.6% |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CSTL | New | CASTLE BIOSCIENCES INC | $461,349 | – | 33,626 | – | 63.00% | – |
| New | AADI BIOSCIENCES INC | $182,395 | – | 26,666 | – | 24.91% | – | |
| SYBX | New | SYNLOGIC INC | $88,540 | – | 205,906 | – | 12.09% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -375,000 | – | -0.27% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -56,250 | – | -1.42% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -205,906 | – | -13.29% | – |
| Exit | AADI BIOSCIENCES INC | $0 | – | -26,666 | – | -25.56% | – | |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -33,626 | – | -59.46% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -45,849 | – | -0.60% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CSTL | New | CASTLE BIOSCIENCES INC | $738,000 | – | 33,626 | – | 54.91% | – |
| New | AADI BIOSCIENCES INC | $329,000 | – | 26,666 | – | 24.48% | – | |
| SYBX | New | SYNLOGIC INC | $237,000 | – | 205,906 | – | 17.63% | – |
| IDRA | New | IDERA PHARMACEUTICALS INC | $26,000 | – | 56,250 | – | 1.94% | – |
| New | NABRIVA THERAPEUTICS PLC | $8,000 | – | 45,849 | – | 0.60% | – | |
| GNCA | New | GENOCEA BIOSCIENCES INC | $6,000 | – | 375,000 | – | 0.45% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -45,849 | – | -2.28% | – | |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -56,250 | – | -2.41% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -4,521 | – | -6.77% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -205,906 | – | -26.09% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -375,000 | – | -29.91% | – |
| Exit | AADI BIOSCIENCES INC | $0 | – | -26,666 | – | -32.53% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | AADI BIOSCIENCES INC | $783,000 | – | 26,666 | – | 32.53% | – | |
| ARPO | Exit | AERPIO PHARMACEUTICALS INC | $0 | – | -400,000 | – | -2.26% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -1,265,631 | – | -91.01% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVIR | New | ATEA PHARMACEUTICALS INC | $27,186,000 | – | 1,265,631 | – | 91.01% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $878,000 | – | 375,000 | – | 2.94% | – |
| SYBX | New | SYNLOGIC INC | $801,000 | – | 205,906 | – | 2.68% | – |
| ARPO | New | AERPIO PHARMACEUTICALS INC | $676,000 | – | 400,000 | – | 2.26% | – |
| LUNG | New | PULMONX CORP | $199,000 | – | 4,521 | – | 0.67% | – |
| IDRA | New | IDERA PHARMACEUTICALS INC | $68,000 | – | 56,250 | – | 0.23% | – |
| New | NABRIVA THERAPEUTICS PLC | $62,000 | – | 45,849 | – | 0.21% | – |